Pharming PHAR
NASDAQ PHAR
$9.75 -0.20 (-2.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pharming (PHAR) Gains from Investment Securities (2019 - 2022)

Updated

Pharming's Gains from Investment Securities came in at -$12.24 million for Q4 2022, compared with -$30,000 a year earlier.

Analysis

Pharming (PHAR) Gains from Investment Securities (2019 - 2022) Analysis & Trends

Going back to Q4 2019, Pharming's Gains from Investment Securities data covers 7 quarters.

  • Going back by year, Gains from Investment Securities was $30,000 in FY2021 (-56.5%), $69,000 in FY2020 (-70.5%), $234,000 in FY2019 (-100.0%) and $584.76 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Pharming 684.14 Mn -146.02 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -12.24 Mn
Sep 30, 2022 326,000.00
Dec 31, 2021 -30,000.00
Sep 30, 2021 15,330.74
Dec 31, 2020 -71,537.39
Sep 30, 2020 54,899.63
Dec 31, 2019 231,339.52
API Access

Pharming Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=PHAR&period=max&api_key=YOUR_API_KEY